Oral Sildenafil for Severe Pulmonary Hypertension Developing after Ibuprofen Use in a Neonate.
| dc.contributor.author | Rodríguez-Castaño, M José | |
| dc.contributor.author | Aleo, Esther | |
| dc.contributor.author | Arruza, Luis | |
| dc.date.accessioned | 2016-11-29T04:34:09Z | |
| dc.date.available | 2016-11-29T04:34:09Z | |
| dc.date.issued | 2016-04 | |
| dc.description.abstract | Background: Severe pulmonary hypertension may following ibuprofen administration for ductal closure. Case characteristics: An extremely preterm infant who developed severe pulmonary hypertension unresponsive to inhaled nitric oxide after ibuprofen administration. Outcome: Pulmonary hypertension reversed after the administration of oral sildenafil, but the infant died due to complications related to bronchopulmonary dysplasia. Message: Sildenafil may have a role in treatment of severe pulmonary hypertension after ibuprofen treatment for ductal closure. | en_US |
| dc.identifier.citation | M José Rodríguez-Castaño, Esther Aleo and Luis Arruza. Oral Sildenafil for Severe Pulmonary Hypertension Developing after Ibuprofen Use in a Neonate. Indian Pediatrics. 2016 Apr; 53(4): 349-350. | en_US |
| dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/178979 | |
| dc.language.iso | en | en_US |
| dc.source.uri | https://www.indianpediatrics.net/apr2016/apr-349-350.htm | en_US |
| dc.subject | Patent ductus arteriosus | en_US |
| dc.subject | Prematurity | en_US |
| dc.subject | Pulmonary vasodilators | en_US |
| dc.title | Oral Sildenafil for Severe Pulmonary Hypertension Developing after Ibuprofen Use in a Neonate. | en_US |
| dc.type | Article | en_US |